Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The first rollout of labels to over 500 individual car part manufacturers while expanding the program should show us all the true proof of the stealth mark application. Gotta gain yardage before scoring a touchdown.
heres another streetsweeper target
http://caps.fool.com/Blogs/goro-accussed-of-fraud/643283
and not an attractive slut at that. i looked the pig up.
Read this link and realize that this has spectrum and vln all over it....already finished recruiting.... phase 3 study to be completed in next 6 months....checkout all who is involved in this study https://clinicaltrials.gov/ct2/show/NCT02139930
Dekon, why the sudden change of heart?
This sure sounds like XXII to me
http://www.thecannabist.co/2016/09/07/colorado-certified-hemp-seeds/62585/
Henrys reply was only dealing whether or not crede is entitled to an injunction in order to receive exchange share period.
court rules prohibit companies motion from addressing any issue other than the specific issues addressed by credes motion for an injunction under the warrants.
Seperately, they filed a three phase motion to dismiss. this is the real meat of the matter.
Honorable Katherine Polk Failla
United States District Court
Southern District of New York
40 Foley Square, Room 2103
New York, NY 10007
Re: Crede CG III, Ltd. v. 22nd Century Group, Inc., No. 1:16-cv-03103-KPF
Dear Judge Failla:
Pursuant to Rule 4(A) of the Court’s Individual Rules and Practices for Civil Cases, Defendant
22nd Century Group, Inc., (“XXII”) requests a pre-motion conference on its anticipated motion to
dismiss for improper venue and motion to dismiss for failure to state a claim for the reasons stated more
fully below. At this time, Plaintiff does not consent to the filing of these motions. Also, XXII notes that
prior to appearance of counsel for XXI, Plaintiff filed a Motion for Preliminary Injunction, and the Court
issued an Order to Show Cause and set a hearing thereon for June 13, 2016. XXII respectfully suggests
that the venue issue should be heard and determined by the Court prior to consideration of the requested
injunction. See 800-Flowers, Inc. v. Intercontinental Florist, Inc., 860 F. Supp. 128, 131 (S.D.N.Y.
1994) (“The propriety of a forum is a threshold matter that the Court must consider before addressing
the merits . . . . Accordingly, before reaching plaintiff’s motion for preliminary injunctive relief, this
Court will consider whether . . . this action is properly before it.”).
Motion to Dismiss or Transfer for Improper Venue: The Amended Complaint should be
dismissed for improper venue under 28 U.S.C. 1406(a) because XXII does not reside in this District and
none of the events or omissions giving rise to the claims occurred in this District. Rather, venue is
proper in the Western District of New York, where: (1) XXII is a resident and has its principal place of
business; (2) a substantial portion of the alleged events or omissions at issue occurred; and (3) the
Shareholder’s Agreement (“JV Agreement”) between the parties – which Plaintiff references as the basis
for Counts I, VI and VII – requires exclusive venue in the Western District of New York for any claims.
Plaintiff’s Amended Complaint should therefore be dismissed for improper venue or, in the alternative,
transferred to the Western District of New York, notwithstanding Plaintiff’s allegations regarding a
different forum selection clause related to certain of its claims. “When venue is challenged, the court
must determine whether the case falls within one of the three categories set out in §1391(b). If it does,
venue is proper; if it does not, venue is improper, and the case must be dismissed or transferred under
§1406. Whether the parties entered into a contract containing a forum-selection clause has no bearing on
whether a case falls into one of the categories of cases listed in §1391(b).” Atlantic Marine Construction
Co. v. United States Dist. Court, 134 S. Ct. 568, 577 (2013); see also Prosperity Bank v. Balboa Music
Festival, LLC, No. 4:13-CV-00288, 2014 WL 1023935, at *3 (S.D. Tex. Mar. 13, 2014) (holding that
notwithstanding a forum selection clause calling for venue in the Southern District of Texas, “ecause
§ 1391(b) applies, the mandatory forum-selection clause in the Ticketing Agreement does not affect the
transfer under § 1406(a). Thus, this case should be dismissed or transferred under § 1406(a) to a district
in which it could have been brought.”). Alternatively, at a minimum, Counts I, VI and VII should be
Case 1:16-cv-03103-KPF Document 18 Filed 05/24/16 Page 1 of 3
May 24, 2016
Page 2
FOLEY & LARDNER LLP
transferred to the Western District of New York pursuant to 28 U.S.C. § 1404(a) due to the exclusive
venue provision in Section 16.12 of the JV Agreement.
Motion to Dismiss for Failure to State a Claim: The Amended Complaint should also be
dismissed for failure to state a claim because the terms of the contracts and documents identified in the
Amended Complaint contradict the allegations by Plaintiff regarding XXII’s supposed duties and
breaches. More specifically:
Count I alleges XXII breached the “Finance Agreement,” identified vaguely in Paragraph 7 of
the Amended Complaint to refer “collectively” to a “network of integrated contracts” intended to sell
tobacco in China. Count I does not identify the specific contract(s) or contract provision(s) allegedly
breached, only that XXII allegedly breached its “express and implied” obligations under the “Finance
Agreement” for failure to pursue the China joint venture. These vague and conclusory allegations fail to
satisfy applicable pleading requirements. Valentini v. Citigroup, Inc., 837 F. Supp. 2d 304, 327
(S.D.N.Y. 2011) (to state “a breach of contract claim, Plaintiff must provide specific allegations as to an
agreement between the parties, the terms of that agreement, and what provisions of the agreement were
breached as a result of the acts at issue.”) (internal quotations omitted).
Further, among the agreements referenced but not attached to the Complaint, only the JV
Agreement identifies obligations in furtherance of the proposed China venture. However, the JV
Agreement does not contain any obligations allegedly breached by XXII, and the JV Agreement
provides that it governs the pursuit of sales in China. Indeed, the JV Agreement makes the joint venture
entity, 22nd Century Asia – and not XXII – responsible for virtually all obligations regarding the China
venture. Recognizing this, Section “C” of the Amended Complaint titles the breach allegations as
“[XXII] Causes 22nd Century Asia to Breach the China JV Agreement.” (Emphasis added). In contrast,
the JV Agreement contains only limited obligations of XXII, which the allegations agree either had been
satisfied (providing a tobacco sample) or the JV Agreement provides were not yet required (contributing
$10M to 22nd Century Asia after XXII’s receipt of an $8.4M license fee from China that did not occur
as required by Section 2.6 of the JV Agreement). Because the JV Agreement contradicts the alleged
duties giving rise to the alleged breach, no breach claim can be stated. See Castorino v. Citibank N.A.,
No. 07 CIV. 10606, 2008 WL 5114482, at *3 (S.D.N.Y. Dec. 5, 2008) (dismissing complaint where
“contract’s terms . . . are squarely at odds with Plaintiff’s breach of contract claim.”). Allegations of an
implied duty of good faith do not change this analysis, as the implied duty cannot impose obligations
inconsistent with the express terms of the contract. See Murphy v. Am. Home Products Corp., 448
N.E.2d 86, 91 (1983).
Counts I and VII also fail because they can be brought by Plaintiff only as derivative claims
since the damages are to 22nd Century Asia, not Plaintiff. The allegations are that the failure to pursue
the China venture caused (Count I) or may cause (Count VII) damage in terms of lost profits and
opportunities. However, pursuant to the JV Agreement, the JV entity, 22nd Century Asia, was the entity
through which products would be sold and distributed in China, and therefore the entity which suffered
or would suffer any alleged damages. Any claim for such alleged mismanagement of 22nd Century Asia
is therefore properly the claim of 22nd Century Asia, and not Plaintiff, who is simply one of the three
shareholders of 22nd Century Asia. See Barry v. Curtin, 993 F. Supp. 2d 347, 352 (E.D.N.Y. 2014)
(“[A]llegations of mismanagement or diversion of assets ... plead a wrong to the corporation only, for
which a shareholder may sue derivatively but not individually,” and “[t]his is true even where . . . the
Case 1:16-cv-03103-KPF Document 18 Filed 05/24/16 Page 2 of 3
May 24, 2016
Page 3
FOLEY & LARDNER LLP
corporation is closely held . . . [and] the majority shareholder is alleged to have participated in the
wrongdoing.”). Further, Plaintiff has not satisfied the prerequisites for bringing a derivative suit on
behalf of 22nd Century Asia, such as, but not limited to, prior demand on 22nd Century Asia’s Board of
Directors. See, e.g., Fed. R. Civ. P. 23.1(b).
Count II seeks rescission of the Securities Purchase Agreement (“SPA”), alleging that XXII
breached the Tranche 1A Warrant Agreement (“Warrant Agreement”) and, thus, Plaintiff may
supposedly rescind the SPA. As explained below, XXII did not breach the Warrant Agreement.
Moreover, the SPA is wholly unrelated to the Warrant Agreement, and neither agreement – both of
which contain integration clauses – refers in any way to the other. The SPA provides only that Plaintiff
will make the $10 million investment in XXII (which $10 million is to be used “for general corporate
purposes” as expressly stated in Section 4(d) of the SPA) and receive XXII common stock in exchange,
which Plaintiff admits occurred. The Warrant Agreement simply provides for the exercise of warrants
under stated conditions. Thus, the Warrant Agreement, and any alleged breach thereof, is irrelevant to
the SPA, and does not support a claim to rescind the SPA. See Septembertide Pub., B.V. v. Stein &
Day, Inc., 884 F.2d 675, 678 (2d Cir. 1989) (“. . . rescission is appropriate only when a breach may be
said to go to the root of the agreement between the parties.”).
In Counts III, IV and V Plaintiff alleges that by reason of the XXII’s March 10, 2016 letter, XXII
blocked Plaintiff from exercising its Exchange Rights in breach of the Warrant Agreement, and seeks a
declaratory judgment, damages and specific performance. However, the subject letter, which Plaintiff
does not attach, identifies in great detail how Plaintiff violated activity restrictions in the Warrant
Agreement by trying to displace XXII management and Board members. By the unambiguous terms of
the Warrant Agreement, these violations expressly entitled XXII to deny the Exchange Rights. Further,
Plaintiff has an adequate remedy at law in the form of money damages and is therefore not entitled to
specific performance or injunctive relief.
Count VI alleges XXII tortiously interfered with the JV Agreement. However, XXII is a party to
the JV Agreement, and cannot tortiously interfere with its own contract. See Solow v. Stone, 994 F.
Supp. 173, 181 (S.D.N.Y.) (“a defendant cannot tortiously interfere with a contract if he is not a third
part[y] unrelated to the contract.”) (internal quotations omitted). Further, because XXII had an economic
interest in the China venture and the JV Agreement, it cannot be liable for tortious interference unless it
acted with malice or employed illegal means. See Vinas v. Chubb Corp., 499 F. Supp. 2d 427, 431
(S.D.N.Y. 2007). Plaintiff’s conclusory allegation of malice is wholly insufficient. See Ruha v. Guior,
277 A.D.2d 116 (2000) (“bare allegations of malice do not suffice, particularly where such allegations
are contradicted by plaintiffs’ own claims that defendants’ actions were financially motived.”).
Count VII seeks an injunction to prevent XXII from pursuing efforts to sell tobacco in China as
allegedly prohibited by the JV Agreement. However, the JV Agreement provides that this exclusivity
prohibition applies only “until termination of this Agreement”. Because the Amended Complaint alleges
that XXII terminated the JV Agreement, this exclusivity provision expressly does not apply.
Respectfully submitted,
/s/ Beth I. Z. Boland
Beth I. Z. Boland, Esq.
cc: Counsel of Record
Case 1:16-cv-03103-KPF Document 18 Filed 05/24/16 Page 3 of 3
Watching metals
With this low float 14k shares just moved this to .075......
With this low float 14k shares just moved this to .075......
The Feds Just Gave Up on Cannabis Prohibition!
By Jeff Siegel | Tuesday, May 10, 2016
You probably didn't read about it on any mainstream media source.
Interestingly, it barely registered a peep on social media, too.
But if you're a legal cannabis investor, it was certainly a “flare gun” moment. The race to legalization, my friend, has officially begun.
Last week, federal prosecutors did something they rarely do: They tucked their tails between their legs and limped away.
Here's how it started...
In 2012, after claiming a violation of federal drug laws, the Justice Department filed a civil forfeiture action against one of the largest medical marijuana dispensaries in California, Harborside Health Center.
But Harborside fought hard and promised it would not abandon its more than 100,000 medical marijuana patients who rely on their medicine to cope with all kinds of illnesses and disorders. Last week, that promise was kept (although Harborside continued to operate during this legal battle).
Last Tuesday, while (ironically enough) sitting in a meeting with a number of legal cannabis investors, I heard the news that the Department of Justice dropped its case against the dispensary. This was huge. Not just for Harborside, but for the entire industry — and, of course, those who profit from it.
Advertisement
Forget useless 401(k)s, pension plans, and 403(b)s
Rogue Maryland wealth expert reveals his secret "blueprint" for how to legally turn $500 into $5 million or more... in less than a year!
This has nothing to do with options, futures, currencies, or any complicated investments.
It’s easy to follow, legal, and could help you make up your retirement gap very, very quickly... even if you have next to nothing saved!
Get the full details here now.
The Beginning of the End
Harborside co-founder and all-around good guy Steve DeAngelo responded to the news, saying that this dismissal signals the beginning of the end of federal prohibition on cannabis.
He's right.
As one of Harborside's attorneys noted, this was a de facto admission by the Justice Department that it simply can't get anywhere pursuing these types of cases where it goes after licensed dispensaries that are compliant with state law.
It's also worth mentioning that the 2014 Rohrabacher-Farr Amendment prevents the feds from spending any federal money to go after medical marijuana businesses in state-regulated markets.
So basically, the federal government no longer has the permission nor the funds to shut down state-approved dispensaries. And by the way, there isn't a single presidential candidate that will approve any kind of crackdown on these state-approved markets.
Translation: The great North American Legal Cannabis Trade is now one step closer to completion.
Advertisement
URGENT: FDA Approval by June 30 ($10 Stock to Surge)
By the end of June, we will see the greatest wealth opportunity of the year — and even our lives.
When the FDA approves a cutting-edge new device that singlehandedly kills Zika, Ebola, and even cancer...
Shares of the tiny $10 stock holding all the patents could surge to $30... $90... $150 and beyond.
This could be your last shot to get in on the ground floor.
Click here to get started.
Don't Waste Time
If you're a regular reader of these pages, you've heard me refer to the great North American Legal Cannabis Trade before. This is the idea that the legal cannabis industry is no longer relegated to just a small number of regions in British Columbia or Denver. Instead, it's now an enormous intra-continental industry worth hundreds of billions of dollars.
Here's the most recent map, highlighting the states and countries in North America where marijuana has been legalized or decriminalized.
oldmap
And this year there are ballot initiatives for legalization (both medical and recreational) in another 14 U.S. states.
Here's that map again, highlighting where cannabis could be legalized by the end of the year.
cannabis legalization end of 2016 map
I'm telling you right now, this is virtually a done deal. And I, for one, will not sit on the sidelines while there's so much money to be made so early in the game.
I certainly hope you're getting a piece of this action, too. And if not, you're wasting valuable time.
The writing is on the wall, the big deals are going down right now, and tomorrow's marijuana millionaires are being made at this very moment. You, dear reader, have an opportunity to be one of them. Click this link, and I'll show you how.
To a new way of life and a new generation of wealth...
Jeff Siegel Signature
Jeff Siegel
Like other scoundrels caught red-handed, convicted con man Barry Minkow says he has renounced crime and found Jesus--and he's banking on his dramatic conversion from Judaism to make a comeback.
Sentenced to 25 years in prison in connection with one of the largest Wall Street scams ever, the founder of the ZZZZ Best carpet-cleaning company in the San Fernando Valley may be paroled from federal prison as early as next July, after serving about a third of his term.
He'll be only 29 and ready for a new career in the public eye: writing and talking about past errors and his redemption through religion. Eventually, he says, he hopes to repay his victims.
Thus are the deeds and misdeeds of the glitzy 1980s transmogrified in the 1990s, as the high rollers of yesteryear struggle to survive in a new era of sobriety. Long gone are the myriad tax shelters, rocketing property values and swelling securities markets that marked the 1980s as a time of easy money unprecedented in American history.
The contrast is especially stark in California, which suffered through the worst recession in the nation following unparalleled real estate inflation. It is here that one easily finds those whose careers symbolized the successes and excesses of the time--and those who now are coping with the decade after.
Legitimate business executives became overextended and endured painful retrenchments. Others started out as legitimate businessmen and became involved in increasingly questionable activities that eventually landed them in trouble. A few seemed headed for trouble from the outset.
Terren Peizer was a financial prodigy who became rich while still in his 20s, working for Michael Milken's marvelous money machine, as Forbes magazine once dubbed Drexel Burnham Lambert's junk bond operation in Beverly Hills.
Thomas Spiegel was a controversial trailblazer in the highly uncertain world of banking deregulation. His relatives were majority shareholders in Beverly Hills-based Columbia Savings, once the fastest-growing thrift in the country.
John Peter Galanis was the ultimate promoter in the golden era of tax shelters. Even then, though, Galanis went about his business largely behind the scenes, because of a previous conviction for securities fraud.
Where are they today?
Peizer is quietly prospering, having distanced himself from Milken and Drexel following his testimony about some of the worst financial excesses of the period.
Spiegel will soon face charges that he looted Columbia Savings & Loan, whose failure could ultimately cost taxpayers more than $1 billion. He says he is innocent.
Galanis is back in jail, with little chance of parole any time in the 20th Century.
*
Terren Peizer would just as soon let go of his past, when he literally worked at Milken's elbow on the legendary black, X-shaped trading desk from which Milken oversaw his financial empire. From there, Peizer had a ringside seat to a financial circus of junk bonds and debt-financed mergers and acquisitions.
When law enforcement officials cracked down on Drexel, Peizer agreed to testify against Milken in exchange for immunity. In the process, he earned the reputation as "the man who ratted out Mike Milken."
Peizer denies he gave up Milken to save himself. For one thing, he says, he did nothing illegal. For another, he notes that he was only one of several witnesses who cooperated with prosecutors.
Now a private investor, Peizer still lives in the condo he bought nine years ago, when he came West to sit at Milken's left hand.
Peizer was brought on to handle the account of money manager David Solomon's firm, a major customer of Drexel junk bonds. He was entrusted with the blue notebook that detailed the deals between Solomon, Milken and a junk bond mutual fund called the Finsbury Fund.
The transactions included generating false commissions, inflating the prices of bonds and creating phony tax losses for Solomon, wrote author James B. Stewart in his best-selling book, "Den of Thieves." Details of the transactions are contained in court documents in the Milken case and in Peizer's testimony.
Peizer says today that he was unaware of the nature of the transactions or their legality: "I didn't really know why we were doing (any of it). I didn't have all the information."
As law enforcement officials closed in, Peizer relinquished control of the blue notebook at Milken's request. But he says he kept copies of other critical Drexel documents, which helped form the basis of a deal to testify against Milken in exchange for immunity.
After being indicted on 98 counts of securities violations, Milken ultimately pleaded guilty in 1990 to six felony charges, including manipulating stock prices, and served two years in prison. (Through a spokeswoman, Milken declined to comment for this article.)
For his part, Peizer has fared well since that time. Now 34, he manages his own investments through a private holding company, Beachwood Financial, named after his hometown in Ohio.
The company's "toxic investor" is Socius Capital Group LLC. Socius is run by Michael S. Wachs of CEOcast. As revealed by Barron’s, Wachs is a “convicted financial felon” who is banned for life from the securities and banking industries. Wachs and two other “big time financial felons” run Socius.
As officially disclosed by FINRA, Wachs “misappropriated $20,800,000 in proceeds by means of false and fraudulent pretenses, representations, and promises for the sale of certain of his member firm’s assets and then diverted the proceeds to himself and others.”
Socius partner Terren S. Peizer is infamous for his role as “left hand man” to convicted felon Michael Milken in the Drexel Burnham Lambert junk bond scandal. Peizer avoided doing hard time by turning “states evidence” and testifying against his mentor.
The third member of the Socius team is convicted felon Richard Josephberg, recently paroled from prison after 21 convictions for fraud, conspiracy and tax evasion over 29 years. In between visits to his parole officer, Josephberg promotes Socius CG and Optimus Capital Partners to unsuspecting CEO’s, using aliases like Rick Berg and Rich Joseph. He is also banned for life from the securities industry. It is no wonder that Wachs, Peizer and Josephberg’s names appear nowhere on Socius’ website.
Socius has been repeatedly sued by issuers for taking their stock and then failing to fund as promised. The three felons appear to be growing increasingly desperate, as word spreads that Socius does not have anywhere near the capital they claim, that the source of their money is a criminal enterprise, and that any company doing business with them risks asset forfeiture and SEC investigation.
Just a few sample links of what public records show for Socius Capital Group:
Michael S. Wachs lifetime ban from the NASD:
http://www.finra.org/web/groups/industry/@ip/@enf/@da/documents/disciplinaryactions/p007557.pdf
Michael Wachs lifetime ban from the Federal Reserve Board:
http://www.federalreserve.gov/boarddocs/press/enforcement/1998/19980206/
New York Times article on Richard Josephberg 50-month prison sentence:
http://www.nytimes.com/2007/09/06/business/06tax.html
LA Times article on Terren S. Peizer’s deal with prosecutors for "ratting out" Michael Milken:
http://articles.latimes.com/1994-07-31/business/fi-22082_1_high-rollers
New York Post article on Terren Peizer and Michael Wachs stock scams:
http://pqasb.pqarchiver.com/nypost/access/1016033001.html?FMT=ABS&FMTS=ABS:FT&date=Apr+5%2C+2006&author=CHRISTOPHER+BYRON&pub=New+York+Post&edition=&startpage=035&desc=GOING+TOO+FARLEY+-+BIG+NAMES%2C+SHADY+FIGURES+LINKED+TO+DRUG+TREATMENT
Barron’s article on Peizer and Wachs stock scams:
http://seekingalpha.com/article/20387-barron-s-expos-of-ceocast-the-fine-print
There are, unfortunately, many many many more examples of the lifetime of misconduct by these people.
Not impressed with the news
I smell acquisition trail on this company.
New cultivation licenses and dealer license issued by Health
Sun Feb 21, 2016 2:44 am
New cultivation licenses and dealer license issued by Health Canada
Health Canada has added two new cultivation licenses to their list of producers and sellers under the MMPR, bringing the total in Canada to 29. British Columbia’s THC Biomed and Ontario’s Green Relief received their licences to cultivate Friday, February 19th.
Located in West Flamborough, Ontario, Green Relief is a 22,000 sq ft aquaponic facility with 15,000 sq ft of cultivation and production space. Aquaponics is the process of combining aquaculture within a hydroponic systems. The facility contains large fish tanks whose waste water, after filtration, will be utilized as fertilizer for the plants. The facility is very ‘green’ focussed, with three of the exterior walls and the roof completely underground with only the south-facing wall exposed.
Located in Kelowna, BC, THC Biomed is a Research and Development company “providing scientific and biotechnological support services” like seeds, clones, testing analysis, extractions services and more to licensed producers. The company also seeks to produce cannabis for wholesale purposes and directly to registered patients.
image from Green Relief's twitter https://twitter.com/GreenRelief_CA/stat ... 8581655552
Image from Green Relief’s Twitter
“We applied for a license that is all encompassing,” John Miller, CEO and President of THC BioMed told equities.com. “We are hopeful if our application is approved to receive wide spectrum of licensing permissions, so we can basically perform any vertical within the cannabis industry. We did not only apply for a license to cultivate and sell marijuana, but we also applied for a license to contract other activities within this space including the ability to perform research and development into the active profiles within the plant in anticipation of conductingclinical trials.”
In addition, Anandia Labs, located in British Columbia, announced they have now received their Dealer’s Licence (NCR Section 9) from Health Canada. A Dealers License allows Anandia to receive cannabis from licensees (other licensed dealers, producers, hemp farmers) for testing purposes, and also cultivate for research purposes. Although Health Canada used to require a separate license for cultivation, the regulations in 2015 to allow cultivation for research purposes with a Dealers Licence.
“The new dealers license gives Anandia the opportunity to move forward with our exciting cannabis research program and also supporting the Canadian cannabis industry in Canada through analytical testing and our extensive knowledge base,” said Anandia Co-Founder, President & CEO, Dr. Jonathan Page.
These new licenses represent a potential shift in Health Canada described recently by David Hyde as an uptick in communication from the regulator to the numerous applicants long waiting in the queue.
360 days is from january 4th so we have til end of the year
6.1 million revenue. Stock traded at a 1.00 with less than half of that. And a small float
Stock manipulators wont last. This is re-entry stock prices for alot of us. $1.50 here we come
New to this board and company overall. I believe with GWPH now showing statistical evidence that CBD helps mitigate seizures that alot of CBD stocks can benefit. How can ZYNE?
Now that Epidiolex reached it’s endpoint, there is statistical evidence that Cbd helps mitigate seizures. There are several “Cbd” companies that can benefit, but only one has the ability to upregulate and downregulate cannabinoids, 22ndCentury Group, XXII (http://www.xxiicentury.com/our-cannabis-hemp-technology). ; The company’s partner, Anandia Labs (http://www.anandialabs.com), is a major player in the Cannabis market in Canada, and there seems to have new momentum in this space.
http://finance.yahoo.com/news/22nd-century-announces-cannabis-research-115000129.html
http://seekingalpha.com/article/2112493-is-22nd-century-group-seeded-for-growth
http://seekingalpha.com/article/2505215-the-purest-play-in-the-cannabis-wave-and-it-trades-on-the-nyse?uprof=42
Now that Epidiolex (GW Pharma’s drug) reached it’s endpoint, there is statistical evidence that Cbd helps mitigate seizures. There are several “Cbd” companies that can benefit, but only one has the ability to upregulate and downregulate cannabinoids, 22ndCentury Group, XXII (http://www.xxiicentury.com/our-cannabis-hemp-technology). ; The company’s partner, Anandia Labs (http://www.anandialabs.com), is a major player in the Cannabis market in Canada, and with this new momentum in the space, i think the stock can do well from here as it is currently not on anyone’s radar in the CBD/medical marijuana sector. IMO
http://finance.yahoo.com/news/22nd-century-announces-cannabis-research-115000129.html
http://seekingalpha.com/article/2112493-is-22nd-century-group-seeded-for-growth
http://seekingalpha.com/article/2505215-the-purest-play-in-the-cannabis-wave-and-it-trades-on-the-nyse?uprof=42
Anandia gives xxii exclusivity in the cannabinoid biosynthetic pathway. I dont think the general population realizes the uses for hemp. Hemp can be refined into hemp seed for food, hemp oil, wax, resin, rope, cloth, paper, plastics and biofuels. Hemp has the longest fiber out of any of the natural fibers. Simply put xx and anandia are looking for the strongest hemp products in the market which was mentioned in the last conference call. Canada and the european unions only permit cultivation of hemp varities that contain less than 0.3% thc which increases the risk to farmers of growing hemp. Decreased thc levels would only benefit to those farmers. And we arnt even talking about the medical marijuana industry.
Specifically the strongest hemp products on the market
This is the away market slicing through. Hedge funds playing the game. All 5,000 blocks show me so on level 2.
Kevin M. Bolin, Experienced Renewable Energy Executive, Named Chairman of the Board of Directors of Q2Power
Mar 01, 2016
OTC Disclosure & News Service
-
Kevin M. Bolin, Experienced Renewable Energy Executive, Named Chairman of the Board of Directors of Q2Power
LANCASTER, OH--(Marketwired - Mar 1, 2016) - Q2Power Technologies (OTCQB: QPWR) announced today that Kevin M. Bolin, a renewable energy senior executive with over 20 years' experience in the sector, has joined the Company's Board of Directors as its Chairman. Mr. Bolin's current and previous industry positions include:
Executive Chairman of the Board and interim CEO of Alter NRG (2009-2015), a publicly-traded (Toronto Stock Exchange) leader in plasma gasification technology acquired from Westinghouse. At Alter NRG, he oversaw the corporate restructuring, operational turnaround, capital raising of over $35 million, and eventual sale of the company in July 2015 at a 160% premium to market which represented a 7x return to investors during his tenure as Chairman.
CEO, President and Director of EnerTech Environmental (1992-2010), a renewable energy and biosolids technology company, which he grew to $20 million in annual sales anchored by long-term contracts valued at $390 million, and raised over $200 million in funding.
Industrial Advisor to EQT Infrastructure (2013-present), a global private equity firm with over 20 Billion Euros under management.
In addition to these accomplishments, Mr. Bolin has won awards, been issued patents, and published numerous articles in the waste and renewable energy sectors. He is a certified public accountant with his BBA from the University of Notre Dame.
"We are honored to welcome Kevin to Q2Power and are confident he will add tremendous value in terms of strategic direction, access to capital, and formation of important alliances with leaders in the waste management and renewable power sectors," stated Christopher Nelson, Q2Power's CEO. "Kevin has already proven to be a very hands-on addition to our team who will provide the support, contacts and validation we need to take Q2Power to the next level."
"I'm excited to work with the solid team at Q2Power on this very interesting opportunity -- developing sustainable waste management ecosystems that help customers reduce operational costs and regulatory burdens," stated Mr. Bolin. "I believe there is great upside for Q2Power's shareholders moving forward, and I look forward to providing the same dedication to making Q2Power a success as Chris and his team have already shown."
Mr. Bolin's compensation as director is comprised solely of stock options, a majority of which vest only as the Company meets critical milestones over the next year, such as recruitment of additional top tier directors, closing of key acquisitions and strategic partnerships and securing long-term capital.
About Q2Power Technologies
Q2Power's technology provides a new, cost-effective solution to dispose of waste by converting it to electricity and useful heat. Because of its containerized, modular design, the system can be deployed with minimal time and expense at thousands of small-scale facilities that must dispose of waste such as used fuels, methane and biogas, at increasingly greater costs. Q2Power installed its first system this summer at an Ohio wastewater treatment plant and is on track to deploy commercial units to meet customer demand for both liquid and gaseous fuels systems early in 2016.
For more information about Q2Power, please visit: www.q2p.com
Legal Notice Regarding Forward-Looking Statements: This news release contains "Forward-looking Statements". These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to our ability to fully commercialize our technology, risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new products and markets, the time and expense involved in such development activities, the ability to secure additional financing, the level of demand and market acceptance of our products, and changes in our business strategies.
Q2P Investor Contact:
Arthur Douglas and Associates
Art Batson
407-478-1120
Q2Power Contact:
Christopher Nelson
CEO
chris@q2p.com
Monday?!? Thats a bold statement. I think its upon us but monday is pretty rough to take. IMO
8K FILED IN NOVEMBER STATES AMONG OTHERS:
Item 2.02. Results of Operations and Financial Condition.
On November 9, 2015, 22nd Century Group, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2015. A copy of the press release is furnished as Exhibit 99.1 herewith and is incorporated herein by reference.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with the settlement agreement described below under Item 8.01, on November 6, 2015, Mr. Joseph Pandolfino resigned from the Board of Directors of the Company effective November 6, 2015.
Item 8.01 Other Events
On November 6, 2015, Mr. Joseph Pandolfino, Alternative Cigarettes (“AC”) and the Company entered into a settlement agreement to resolve all disputes among the parties, with the primary provisions of such settlement agreement being as follows:
1. Mr. Pandolfino agreed to and did resign from the Company’s Board of Directors on November 6, 2015.
2. Mr. Pandolfino entered into a lock-up agreement with the Company pursuant to which Mr. Pandolfino has agreed to not sell, pledge or otherwise encumber or transfer any shares of the Company’s common stock beneficially owned by Mr. Pandolfino during the period from the date of the settlement agreement through December 31, 2016, subject to the Company making all of the severance payments as described in paragraph number 5 below and the consulting payments described in paragraph number 6 below in a timely manner.
3. Subject to the Company making all of the severance payments and consulting payments described in paragraph numbers 5 and 6 below in a timely manner, Mr. Pandolfino agreed that he: (i) shall not vote any Company securities against the reelection of any of the current directors of the Company, and (ii) shall not vote for, or provide any support whatsoever for, any change in control of the Company or any of its affiliates or any candidate for election to the Board of Directors of the Company unless such candidate has been selected and endorsed by the Nominating Committee of the Board of Directors of the Company.
joey cant sell. Hes locked up
NEW COMMISIONER OF FDA JUST CONFIRMED. LOOKS LIKE ONE OF HIS TOP PRIORITIES IS TO GAIN AUTHORITY TO REGULATE ECIGS. THIS COULD LEAD TO A FASTRACK FOR THE FDA TO PUSH VLN THROUGH. JUST LIKE CONFERENCE CALL STATED BY HENRY. THE FDA IS FULFILLED WITH XX STUDIES AND TRIALS. THEY HAVE EVERYTHING THEY NEED FROM XX AND VLN AND SEEMED SATISIFIED.
http://www.reuters.com/article/us-usa-fda-commissioner-idUSKCN0VX2FL
If anybody here attended any of the dinners in california, florida, new york or chicago then you heard it there.
An offer of a 1 billion buyout was already brought to the table a few years ago. This per henry at the XXII dinner presentation for investors.